Abstract
Asthma is now recognized to be a chronic inflammatory disease of the airways, involving mast cells, eosinophils, and T lymphocytes. Treatment of asthma should therefore be based on anti-inflammatory agents rather than bronchodilators. Choices include inhaled corticosteroids, which are highly effective in all patients, and cromolyn sodium and nedocromil sodium, which are effective in patients with mild asthma. It is likely that the earlier and more widespread use of anti-inflammatory drugs will reduce the unacceptably high morbidity and mortality of asthma and prevent irreversible chronic airflow obstruction in patients with severe disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
